Cancer Cell International

Papers
(The TQCC of Cancer Cell International is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment269
New insights into M1/M2 macrophages: key modulators in cancer progression181
Challenges of applying multicellular tumor spheroids in preclinical phase148
p53 signaling in cancer progression and therapy139
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment126
circRNA-miRNA-mRNA regulatory network in human lung cancer: an update121
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine120
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review113
Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future102
The biological function of m6A demethylase ALKBH5 and its role in human disease97
The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations95
The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers79
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier78
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer71
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk67
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer64
Polyamines and related signaling pathways in cancer63
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets62
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer62
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma61
Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis59
CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)59
Emerging roles of RNA methylation in gastrointestinal cancers57
FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport55
CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis53
Dynamic regulation and functions of mRNA m6A modification53
RETRACTED ARTICLE: Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis53
Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review52
SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway50
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma49
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway48
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma47
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma47
LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L147
Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC47
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF147
Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis47
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer46
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification46
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer45
Myricetin: targeting signaling networks in cancer and its implication in chemotherapy45
Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment45
The yin and yang functions of extracellular ATP and adenosine in tumor immunity45
Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells44
Induction and application of ferroptosis in cancer therapy44
Recent advances and limitations of mTOR inhibitors in the treatment of cancer44
Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway44
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma43
Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis42
Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients42
The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis41
Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade41
The biological function of m6A reader YTHDF2 and its role in human disease41
Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis41
Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways40
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)40
SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer40
CRNDE: an oncogenic long non-coding RNA in cancers40
Cancer-related circular RNA: diverse biological functions38
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment38
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures38
M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG338
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma37
Triple-negative breast cancer: understanding Wnt signaling in drug resistance37
Emerging role of long noncoding RNA-encoded micropeptides in cancer37
Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p37
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress37
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin37
Protein kinase function of pyruvate kinase M2 and cancer37
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients37
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma36
Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis36
Geriatric nutritional risk index as a predictor of complications and long-term outcomes in patients with gastrointestinal malignancy: a systematic review and meta-analysis36
Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines36
Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease36
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer36
Circular RNA circPITX1 knockdown inhibits glycolysis to enhance radiosensitivity of glioma cells by miR-329-3p/NEK2 axis36
LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway36
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment36
The expression profiles and prognostic values of HSPs family members in Head and neck cancer35
LncRNA SNHG3, a potential oncogene in human cancers35
CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression35
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma35
Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis35
Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance35
MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma34
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer34
BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes34
Autophagy regulation using luteolin: new insight into its anti-tumor activity34
Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer34
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice33
YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF433
Long non-coding RNASNHG17 promotes the progression of breast cancer by sponging miR-124-3p32
Ovarian cancer: epigenetics, drug resistance, and progression32
Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-732
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction32
lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis32
MicroRNAs and angiogenesis: a new era for the management of colorectal cancer32
miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway32
Signaling pathways of EBV-induced oncogenesis32
LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis32
Matrine inhibits cell growth, migration, invasion and promotes autophagy in hepatocellular carcinoma by regulation of circ_0027345/miR-345-5p/HOXD3 axis32
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review32
SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells31
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)31
Circular RNA ITCH suppresses proliferation, invasion, and glycolysis of ovarian cancer cells by up-regulating CDH1 via sponging miR-106a31
Reshaping the role of m6A modification in cancer transcriptome: a review31
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review31
FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis31
Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion30
Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma30
Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies30
CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p30
The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review30
Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis30
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches30
Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p30
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy29
Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma29
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes29
LncRNA & Wnt signaling in colorectal cancer29
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics29
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma29
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview29
LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway29
Potential of antibody–drug conjugates (ADCs) for cancer therapy29
CircRNA DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis29
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers28
CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR-18228
Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness28
Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway28
CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis28
Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma28
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma28
The regulatory role of antisense lncRNAs in cancer28
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis28
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies28
CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model28
A review on the advances and challenges of immunotherapy for head and neck cancer28
The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis28
Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma27
CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p27
Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p27
The emerging roles of circular RNAs in ovarian cancer27
MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the ANGPT2/NOD_LIKE_RECEPTOR axis27
Circ_0032821 acts as an oncogene in cell proliferation, metastasis and autophagy in human gastric cancer cells in vitro and in vivo through activating MEK1/ERK1/2 signaling pathway27
The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer27
Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR/MAPK signaling pathway via inhibiting ERRFI127
Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis27
Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma27
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer27
Chemoprotective and chemosensitizing effects of apigenin on cancer therapy27
A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound27
Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer27
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells26
Curcumin anti‐tumor effects on endometrial cancer with focus on its molecular targets26
Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis26
CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells26
Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro26
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer26
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature26
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer26
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis26
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives26
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis26
Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study26
Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells26
Long non-coding RNA GAS5 accelerates oxidative stress in melanoma cells by rescuing EZH2-mediated CDKN1C downregulation26
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer26
Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis25
Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis25
M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT25
LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis25
CircRNA_100290 promotes GC cell proliferation and invasion via the miR-29b-3p/ITGA11 axis and is regulated by EIF4A325
MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression25
SOX4 promotes the growth and metastasis of breast cancer25
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway25
M2 macrophages‐derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 8225
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammato25
Long non-coding RNA NEAT1/miR-338-3p axis impedes the progression of acute myeloid leukemia via regulating CREBRF24
Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-60124
Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma24
HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cells24
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory24
The role of Th17 cells in the pathogenesis and treatment of breast cancer24
Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells24
Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections24
MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer24
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway24
The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma24
LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression24
Hsa_circ_0026416 promotes proliferation and migration in colorectal cancer via miR-346/NFIB axis24
Skp2 modulates proliferation, senescence and tumorigenesis of glioma24
LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells24
Long non-coding RNA DANCR promotes cervical cancer growth via activation of the Wnt/β-catenin signaling pathway24
Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis24
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers24
Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma24
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma24
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC24
LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells24
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model23
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance23
RNA m6A methylation regulators in ovarian cancer23
YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells23
LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer23
LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancer23
Fatty acid oxidation: driver of lymph node metastasis23
LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis23
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma23
Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway23
Circ_LDLR promoted the development of papillary thyroid carcinoma via regulating miR-195-5p/LIPH axis23
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells23
LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p23
Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer23
The relationship between TRAF6 and tumors23
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT23
Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer23
Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma23
Anticancer effects of bifidobacteria on colon cancer cell lines23
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer22
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization22
Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p22
Targeting Nrf2 may reverse the drug resistance in ovarian cancer22
Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells22
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death22
Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis22
Circular RNA and tumor microenvironment22
Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage22
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma22
LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p/ZNF70322
Engineered exosomes loaded with miR-449a selectively inhibit the growth of homologous non-small cell lung cancer22
Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis22
Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma22
LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-392422
Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p22
Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM122
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy22
Recent insights into eukaryotic translation initiation factors 5A1 and 5A2 and their roles in human health and disease22
RETRACTED ARTICLE: CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis22
Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients22
The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know22
miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC122
LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH122
SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis21
MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation21
Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes21
LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis21
Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression21
LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling21
0.026176929473877